Clear Street’s Moderna MRNA Stock Holding History

Clear Street’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13,000	Closed	-$1.34M	–	903
2023 Q3	$1.34M	Buy	+13,000	New	+$1.45M	0.02%	82
2023 Q1	–	Sell	-100,000	Closed	-$18M	–	1232
2022 Q4	$18M	Buy	+100,000	New	+$16.4M	0.23%	45

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Clear Street's MRNA Position: Q1 2026 in Review

Clear Street opened a new position in Moderna (MRNA) in Q1 2026: 11,008 shares worth $559K. The stake represents ﹤0.01% of the portfolio and ranks #455 among its holdings. This is a return to the name: Clear Street previously reported a position in MRNA as recently as Q3 2023.

Clear Street first reported a position in MRNA in Q4 2022 and has held it in 3 quarters since. The position peaked at $18M in Q4 2022. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Clear Street held 11,008 shares of Moderna worth $559K as of Q1 2026.
Moderna was a new Clear Street position in Q1 2026.
Moderna made up ﹤0.01% of Clear Street's portfolio in Q1 2026, its #455 holding.
Clear Street first reported a position in Moderna in Q4 2022 and has held it in 3 quarters since.
Clear Street's Moderna position peaked at $18M in Q4 2022.
723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.